Marco G. Paggi

Citado por

	Total	Desde 2019
Citas	6815	1511
Índice h	46	24
Índice i10	109	42

340

170

255

198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202424 24 26 36 32 32 53 33 45 54 45 55 106 144 93 127 134 137 204 210 168 231 214 206 250 218 266 296 308 277 306 294 315 238 265 326 305 270 255 90

Acceso público

Ver todo

19 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Anna Maria MileoIFO- senior scientistDirección de correo verificada de ifo.gov.it
ANTONIO GIORDANODirector & Professor, Sbarro Institute, Temple University ; University of SienaDirección de correo verificada de temple.edu
Antonio De LucaProfessore di anatomia umana seconda università napoliDirección de correo verificada de unina2.it
Armando FelsaniCNRDirección de correo verificada de cnr.it
nicola perrottiprofessore di genetica medica. dipartimento scienze della salute. universita' di catanzaroDirección de correo verificada de unicz.it
Rosario Amatoprofessore di genetica medica, Universita' degli Studi Magna Graecia di CatanzaroDirección de correo verificada de unicz.it
paola MatarreseIstituto superiore di sanitàDirección de correo verificada de iss.it
Mauro PicardoSan gallicano Dermatologic InstituteDirección de correo verificada de ifo.gov.it
Pier Paolo ClaudioUniv. of Mississippi, Prof. Dept. of BioMolecular Sciences, National Center Natural Product ResearchDirección de correo verificada de olemiss.edu
Maria De FalcoDepartment of Biology, University Federico II of NaplesDirección de correo verificada de unina.it
Patrizia LaviaInstitute of Molecular Biology and Pathology CNR, Roma ItalyDirección de correo verificada de uniroma1.it
Francesca MusumeciUniversity of GenoaDirección de correo verificada de unige.it
Douglas NoonanUniversità degli Studi dell’InsubriaDirección de correo verificada de uninsubria.it
Adriana AlbiniIRCCS Istituto Europeo di Oncologia-IEO, MilanoDirección de correo verificada de ieo.it
Vincenzo DattiloDirección de correo verificada de unicz.it
Miranda MennitiuniczDirección de correo verificada de unicz.it
Stefano AlcaroNet4Science spinoff & Dipartimento di Scienze della Salute - UMG di Catanzaro (Italy)Dirección de correo verificada de unicz.it
Francesco OrtusoUniversità "Magna Graecia" di CatanzaroDirección de correo verificada de unicz.it
Valter AgostiUniversity of Catanzaro "Magna Graecia"Dirección de correo verificada de unicz.it
Anna BagnatoIstituto Nazionale Tumori Regina ElenaDirección de correo verificada de ifo.it

Seguir

Marco G. Paggi

IRCCS Regina Elena National Cancer Institute, Rome, Italy

Dirección de correo verificada de ifo.it

Oncology molecular biology molecular pathology cell cycle clinical pharmacology


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Unravelling the complexity of T cell abnormalities in common variable immunodeficiency A Giovannetti, M Pierdominici, F Mazzetta, M Marziali, C Renzi, AM Mileo, ... The Journal of Immunology 178 (6), 3932-3943, 2007	337	2007
Retinoblastoma protein family in cell cycle and cancer: a review MG Paggi, A Baldi, F Bonetto, A Giordano Journal of cellular biochemistry 62 (3), 418-430, 1996	288	1996
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells A Floridi, MG Paggi, ML Marcante, B Silvestrini, A Caputo, C de Martino Journal of the National Cancer Institute 66 (3), 497-499, 1981	275	1981
Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells A Floridi, MG Paggi, S D'Atri, C De Martino, ML Marcante, B Silvestrini, ... Cancer research 41 (11_Part_1), 4661-4666, 1981	242	1981
The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells A Baldi, AD Luca, M Morini, T Battista, A Felsani, F Baldi, C Catricala, ... Oncogene 21 (43), 6684-6688, 2002	240	2002
Contributions of glycolysis and oxidative phosphorylation to adenosine 5′-triphosphate production in AS-30D hepatoma cells RA Nakashima, MG Paggi, PL Pedersen Cancer research 44 (12_Part_1), 5702-5706, 1984	232	1984
Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins A Felsani, AM Mileo, MG Paggi Oncogene 25 (38), 5277-5285, 2006	199	2006
nm23: Unraveling its biological function in cell differentiation D Lombardi, ML Lacombe, MG Paggi Journal of cellular physiology 182 (2), 144-149, 2000	187	2000
Functional analysis of pRb2/p130 interaction with cyclins PP Claudio, A De Luca, CM Howard, A Baldi, EJ Firpo, A Koff, MG Paggi, ... Cancer research 56 (9), 2003-2008, 1996	160	1996
Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line RA Nakashima, MG Paggi, LJ Scott, PL Pedersen Cancer research 48 (4), 913-919, 1988	157	1988
Distribution of the serine protease HtrA1 in normal human tissues A De Luca, M De Falco, A Severino, M Campioni, D Santini, F Baldi, ... Journal of Histochemistry & Cytochemistry 51 (10), 1279-1284, 2003	148	2003
Activation of human B-MYB by cyclins A Sala, M Kundu, I Casella, A Engelhard, B Calabretta, L Grasso, ... Proceedings of the National Academy of Sciences 94 (2), 532-536, 1997	134	1997
Genetic and epigenetic alterations as hallmarks of the intricate road to cancer M Macaluso, MG Paggi, A Giordano Oncogene 22 (42), 6472-6478, 2003	133	2003
Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study P Matarrese, B Ascione, L Ciarlo, R Vona, C Leonetti, M Scarsella, ... Molecular cancer 9, 1-14, 2010	125	2010
Effects of assessing the productivity of faculty in academic medical centres: a systematic review EA Akl, JJ Meerpohl, D Raad, G Piaggio, M Mattioni, MG Paggi, A Gurtner, ... Cmaj 184 (11), E602-E612, 2012	123	2012
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation R Amato, L D’Antona, G Porciatti, V Agosti, M Menniti, C Rinaldo, N Costa, ... Journal of molecular medicine 87, 1221-1239, 2009	115	2009
Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress V Maresca, E Flori, S Briganti, A Mastrofrancesco, C Fabbri, AM Mileo, ... Pigment Cell & Melanoma Research 21 (2), 200-205, 2008	108	2008
The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cycle regulated A Baldi, A De Luca, PP Claudio, F Baldi, GG Giordano, M Tommasino, ... Journal of cellular biochemistry 59 (3), 402-408, 1995	108	1995
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas C Abbruzzese, S Mattarocci, L Pizzuti, AM Mileo, P Visca, B Antoniani, ... Journal of experimental & clinical cancer research 31, 1-7, 2012	104	2012
Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother MG Paggi, A Giordano Cancer research 61 (12), 4651-4654, 2001	104	2001

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores